Breaking News
Get 40% Off 0
Is NVDA a 🟢 buy or 🔴 sell? Unlock Now

ProPicks: Beat the S&P 500 with our cutting-edge AI-powered stock selection

Published Dec 04, 2023 02:04AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters
 
US500
+0.17%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
PFE
-1.07%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
ON
-0.77%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
CNC
+0.21%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

Institutions and billionaire investors worldwide are already well ahead of the game when it comes to AI-powered investing, extensively using, customizing, and developing it to bulk up their returns and minimize losses.

Now, InvestingPro users can do just the same for under $9 a month our new flagship AI-powered stock-picking tool: ProPicks.

By combining over 50 financial signals, ProPicks leverages the power of AI to bring you six actively managed strategies that will help you beat the market by a comfortable margin both in good and difficult times.

Today, we will have a look at the first strategy in our list: Beat the S&P 500.

As the name implies, this strategy leverages advanced AI models to analyze financial data from all 500 stocks in the S&P 500 index, with a focus on identifying the top 20 performers each month that exhibit the highest potential for outperformance.

Historical data shows that our strategy would have beaten the market by a wide margin over the last decade, as seen in the chart below:Beat the S&P 500 Vs. MarketSource: InvestingPro ProPicks

The strategy is rebalanced on a monthly basis, guaranteeing that our users stay ahead of curve amid shifting market dynamics and an ever-changing macroeconomic environment.

Let's take a deeper look at three of the stocks currently highlighted within the Beat the S&P 500 strategy, namely Pfizer , ON Semiconductor , and Centene to understand why they are likely to outperform the market going forward.

Want to see all the stocks in this strategy? Subscribe now for under $9 a month and start outperforming the market now!

1. ON Semiconductor (ON)

  • InvestingPro Health Label: Great
  • InvestingPro Fair Value: Undervalued (26.4% Upside)
  • Forward P/E Ratio: 13.8x

ON Semiconductor (NASDAQ:ON) provides intelligent sensing and power solutions in the United States and internationally. Its intelligent power technologies enable the electrification of the automotive industry that allows for lighter and longer-range electric vehicles, empowers fast-charging systems, and propels sustainable energy for the solar strings, industrial power, and storage systems.

What do Wall Street analysts say?

According to analysts surveyed by InvestingPro, ON Semiconductor is Undervalued with 25.7% Upside.

Most recently, in November, Roth/MKM initiated coverage on ON Semiconductor with a Buy rating. In October, Craig-Hallum and Summit Insights downgraded the stock from Buy to Hold, and Baird downgraded from Outperform to Neutral with a price target of $60.00 (from $120.00), writing:

In addition to a resumption of under-utilization charges across analog companies, lead times are rapidly normalizing, which should bring pricing pressures, in our view. We view 2H22 as a mid-cycle correction, not a true downturn.

Key recent news

In October, ON Semiconductor reported Q3 earnings of $1.39 per share on revenue of $2.18 billion. Analysts were looking for $1.34 earnings on revenue of $2.15B.

Furthermore, the company announced that they will be reducing their workforce by 900 jobs as they foresee a sluggish Q4.

2. Centene (CNC)

  • InvestingPro Health Label: Great
  • InvestingPro Fair Value: Undervalued (39.8% Upside)
  • Forward P/E Ratio: 16.1x

Centene (NYSE:CNC) operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. It operates in two segments, Managed Care and Specialty Services.

Shares are up 6.8% in the past month and down 10.2% year to date.

What do Wall Street analysts say?

According to analysts surveyed by InvestingPro, Centene is Fairly valued with 17.7% Upside.

Most recently, in September, BofA Securities upgraded Centene from Underperform to Neutral with a price target of $72.00 (from $79.00).

The company is now trading below 10x 2024E EPS, which is historically a floor for MCO valuations, while the new earnings expectations have been rebased to (at least partially) include most of the major risks (RFP losses, Medicaid redeterminations, MA margins).

3. Pfizer (PFE)

  • InvestingPro Health Label: Great
  • InvestingPro Fair Value: Undervalued (41.6% Upside)
  • Forward P/E Ratio: 16.4x
  • Dividend Yield: 5.4%

Pfizer (NYSE:PFE) is a world-renowned pharmaceutical behemoth with a massive number of well-known brands under its umbrella, including its COVID-19 vaccines and potential future mRNA and antiviral products.

What do Wall Street analysts say?

According to analysts surveyed by InvestingPro, Pfizer is Fairly valued with 24.7% Upside.

Most recently, in October, Jefferies upgraded Pfizer to Buy from Hold, and UBS started coverage on the stock at Neutral, writing:

“Pfizer screens well, in our view, with some investors sensing a potential trough. However, we see it being tough to turn sentiment around given a lack of meaningful catalysts on the horizon, continuing uncertainty over COVID, and less BD optionality post-Seagen.”

Want to see all picks from our list of 70+ market-beating stocks? Subscribe now for under $9 a month and never miss another bull market again!Subscribe Now!

ProPicks: Beat the S&P 500 with our cutting-edge AI-powered stock selection
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email